Auto-generated from public data. Not the firm's stated position.
STOAF appears to focus on growth-stage and series-c investments across biotech, cleantech, and manufacturing sectors, with recent portfolio activity suggesting an interest in specialized diagnostics, AI-driven optimization, and financial technology platforms. Based on disclosed data, the firm deploys checks in the €3.0M range and maintains a geographically anchored presence in Sweden.
Generated 1 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
Auto-detected from STOAF's website.
30+ years in pharma from senior positions at large and startup companies with 140+ peer-reviewed publications and CEO experience.
Managing GP of Stoaf Start II with entrepreneurial background and senior IT positions, focused on sustainable energy ventures.
Former Gartner Group Vice President with 20+ years consulting experience and deep tech expertise including VR and nuclear physics background.
Retired Gartner Executive Vice President with 20 years experience overseeing 30,000+ client engagements and hi-tech venture investing.
Focus and check size from the firm's website. Website reachable as of Oct 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.